✦ LIBER ✦

Natural history of hbeag-negative chronic Hepatitis b

✍ Scribed by Marc G. Ghany; T. Jake Liang

Book ID: 107540442
Publisher: Current Science Inc.
Year: 2006
Tongue: English
Weight: 229 KB
Volume: 5
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-006-0020-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamivudine in HBeAg-negative

Efficacy of lamivudine in HBeAg-negative chronic hepatitis B

✍ Mario Rizzetto 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract Hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B results from infection with hepatitis B virus mutants unable to produce HBeAg. It accounts for 7–30% of patients with chronic hepatitis B virus (HBV) worldwide, with the highest rates reported for Mediterranean Europe and Asia.

Natural history of chronic hepatitis B

✍ Alfredo Alberti; Giovanna Fattovich 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 543 KB

New perspectives in the treatment of HBe

New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B

✍ Thomas Berg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

BACKGROUND: Available treatments for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are associated with poor sustained responses. As a result, nucleoside and nucleotide analogues are typically continued indefinitely, a strategy associated with the risk of resistance and unknown long-term

Hepatitis B genotypes and precore/basal

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

✍ Chih-Lin Lin; Li-Ying Liao; Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Jia-Horng 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 61 KB

The natural history of chronic hepatitis

The natural history of chronic hepatitis B virus infection

✍ Brian J. McMahon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are identified: an immune tolerant phase with high HBV DNA and normal alanine aminotransferase (ALT) levels associated with minimal liver disease; an immune active phase with high HBV DNA and elevated ALT levels with ac

Changes in the prevalence of HBeAg-negat

Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B

✍ Keisuke Hamasaki; Keisuke Nakata; Yuji Nagayama; Akira Ohtsuru; Manabu Daikoku; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Hepatitis B virus with a G-to-A point mutation at nucleotide 83 in the precore region (mutant hepatitis B virus 83), which cannot produce HBeAg, is commonly found in HBe antibody-positive hepatitis B virus carriers. We analyzed the consecutive changes in the prevalence of mutant hepatitis B virus 83